Health CanadaType II
PMS-Pazopanib 200 mg tablet; Presence of Sorafenib
Published: May 31, 2023Recall ID: 73740Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
PMS-Pazopanib 200 mg tablet
Additional Source Details
| Field | Value |
|---|---|
| N I D | 73740 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/pms-pazopanib-200-mg-tablet-presence-sorafenib |
| Issue | Product quality |
| Title | PMS-Pazopanib 200 mg tablet; Presence of Sorafenib |
| Product | PMS-Pazopanib 200 mg tablet |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2023-05-31 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |